deltatrials
Active Not Recruiting OBSERVATIONAL NCT02284308

Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the Optimal Treatment Strategy (ELDAPT)

ELDAPT: Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the oPtimal Treatment Strategy

Sponsor: AstraZeneca

Conditions NSCLC
Updated 13 times since 2017 Last updated: Jul 2, 2025 Started: Jul 31, 2016 Primary completion: Jan 1, 2025 Completion: Dec 18, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates NSCLC and is currently ongoing. AstraZeneca leads this study, which shows 13 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Sep 2017 · 7 months · monthly snapshot~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshot~Jun 2018 – ~Feb 2020 · 20 months · monthly snapshot~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshot~Jan 2021 – ~Oct 2021 · 9 months · monthly snapshot~Oct 2021 – ~Apr 2023 · 18 months · monthly snapshot~Apr 2023 – ~Jul 2024 · 15 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Aug 2025 · 6 months · monthly snapshot~Aug 2025 – ~Sep 2025 · 31 days · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting

  2. Aug 2025 — Sep 2025 [monthly]

    Active Not Recruiting

  3. Feb 2025 — Aug 2025 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  4. Sep 2024 — Feb 2025 [monthly]

    Recruiting

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting

▶ Show 8 earlier versions

  1. Apr 2023 — Jul 2024 [monthly]

    Recruiting

    Phase: NA → None

  2. Oct 2021 — Apr 2023 [monthly]

    Recruiting NA

  3. Jan 2021 — Oct 2021 [monthly]

    Recruiting NA

  4. Feb 2020 — Jan 2021 [monthly]

    Recruiting NA

  5. Jun 2018 — Feb 2020 [monthly]

    Recruiting NA

  6. Sep 2017 — Jun 2018 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting · Phase: PHASE3 → NA

  7. Feb 2017 — Sep 2017 [monthly]

    Not Yet Recruiting PHASE3

  8. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
  • Dutch Cancer Society
  • Dutch Society of Physicians for Pulmonology and Tuberculosis
  • Erasmus Medical Center
  • Maastricht Radiation Oncology
  • VieCuri Medical Centre
Data source: Maastricht Radiation Oncology

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Almelo, Netherlands , Apeldoorn, Netherlands , Arnhem, Netherlands , Deventer, Netherlands , Ede, Netherlands , Eindhoven, Netherlands , Enschede, Netherlands , Gorinchem, Netherlands , Gouda, Netherlands , Heerlen, Netherlands and 7 more locations